AZD1305 Single and Multiple Ascending Dose Study in Healthy Japanese and Caucasian Subjects - JMAD

Study identifier:D3190C00015

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Terminated/Withdrawn

Official Title

A Single-center, Single-blind, Randomized, Placebo-controlled, Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics After Single and Multiple Ascending Oral Doses of AZD1305 Extended-release Capsules in Healthy Male Japanese and Caucasian Subjects

Medical condition

Healthy

Phase

Phase 1

Healthy volunteers

Yes

Study drug

AZD1305, Placebo

Sex

Male

Actual Enrollment

Study type

Interventional

Age

20 Years - 45 Years

Date

Study Start Date: 01 Jul 2009

Primary Completion Date: 01 Nov 2009

Study Completion Date: 01 Nov 2009

Study design

Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Basic Science

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Collaborators

Inclusion and exclusion criteria

Location

Research Site

Glendale, CA, United States

Location

Research Site

Baltimore, MD, United States

Arms	Assigned Interventions
Experimental: 1, AZD1305	Drug: AZD1305 single and multiple oral doses, extended-release capsule
Placebo Comparator: 2, Placebo	Drug: Placebo single and multiple oral doses, capsule

"There is no result for the study"

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=1327&filename=CSR-D3190C00015.pdf
Download
CSR-D3190C00015.pdf
Download
Trial Results Summaries
Available here

Contacts

Contact

Betsy Geishen Scott

410-350-7918

Betsy.GeishenScott@parexel.com

Investigators

Principal Investigator

Mark Yen

California Clinical Trials

AZD1305 Single and Multiple Ascending Dose Study in Healthy Japanese and Caucasian Subjects - JMAD

Official Title

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Age

Date

Study design

Verification:

Sponsors

Collaborators

Inclusion Criteria

Exclusion Criteria

Research Site

Research Site

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=1327&filename=CSR-D3190C00015.pdf

CSR-D3190C00015.pdf

Trial Results Summaries

Contacts

Contact

Investigators

Principal Investigator